*June 2024* This recorded zoom call features our co-founder Jill Feldman and leading advocate Dusty Donaldson. This is the project of an IASLC Patient Educational Award winner Yvonne Diaz, aimed at encouraging more advocacy efforts in lung cancer.  Jill and Dusty discuss everything from getting started to a range of…

*March 2024* Podcast Host:  Hildy Grossman with Jordan Rich, co-host Podcast Guests: Cheryl Davis, of Red Thred Solutions; Lauren Coye, Patient and Patient Advocate What often goes unheard in medical situations is the patient’s voice. Our guests have a lot to say about this matter. Cheryl Davis has extensive experience…

*March 2024* Sharing your stories and experiences as someone impacted by lung cancer can help create positive change. Whether you are a patient, survivor, caregiver, healthcare provider, family member, or friend, adding your voice as a lung cancer advocate can help humanize important issues and statistics for policymakers and decision-makers.…

*March 2024* The American Society of Clinical Oncology (ASCO) has announced Jill Feldman, as the recipient of the 2024 ASCO Patient Advocate Award. This award acknowledges Dr. Newman’s dedication and contributions to the field of global oncology. Jill Feldman, is a lung cancer patient and passionate advocate with a personal connection to the cause.…

*March 2024* For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. They’ve ignited a movement to radically change how new cancer drugs are tested, with the U.S. Food and…

Many of the things we take for granted as lung cancer patients are those people who have made a difference to our lives either by working for more research funding, making sure that clinical trial and lung caner guidelines as well as cancer care are more patient-centric. We benefit in many ways from…

*November 2023* Patients want improved efficacy, but not necessarily at the expense of their quality of life. Combination treatment comes with increased toxicities, which make maintaining a normal life more difficult. Even grade 1 side effects such as diarrhea or nausea can make it difficult to hold a job or…

*September 2023* Incredible advancements in lung cancer research and treatment have been reported during the 2023 World Conference on Lung Cancer, but the stigma surrounding lung cancer remains a deadly problem, according to Jill Feldman, a lung cancer patient and Chair of IASLC’s Patient Advocates Committee. “There’s an undeniable blame…

*September 2023* As you may know, the EGFR Resisters are partnering with LUNGevity for 2 more research projects that are focused on EGFR+ lung cancer research. Since we launched our shirt sales fundraising campaign, we have added an additional $1,521 to our funds so please keep your family and friends…

*July 2023* This article is written by Laura Greco, a lung cancer patient and advocate. It has been observed that “the development of brain metastases is one of the most feared complications of cancer due to the substantial neurocognitive morbidity and a grim prognosis.”1 In my own case, when I…